Biotech

All Articles

Vir increases 3 T-cell engagers coming from Sanofi, lays off 25% of workers

.Vir Biotechnology's second-quarter incomes report wasn't except big news. The company invited a tri...

Galapagos stops briefly CAR-T tissue therapy trial over Parkinsonism instance

.Galapagos has stopped briefly enrollment in a test of a BCMA-directed CAR-T tissue therapy, pushing...

James Wilson leaving Penn to launch 2 brand-new biotechs

.After greater than three decades, genetics treatment trailblazer James Wilson M.D., Ph.D., is leavi...

3 biotechs make an effort to beat the summer heat energy by shedding team

.As biotechs seek to switch a fresh webpage in August, at the very least three providers have actual...

venBio raises $528M for 5th life sciences VC fund

.Pro venture capital company venBio has raised one more half a billion bucks to invest in biotechs w...

Otsuka pays $800M for Jnana and also its own clinical-stage PKU drug

.Otsuka Pharmaceutical has actually picked up Boston-based Jnana Therapies for $800 million so the E...

FibroGen lays off 75% of US workers as possession flunks 2 even more trials

.FibroGen is actually substantially restructuring its business, laying off 75% of its united state p...

Tracon winds down full weeks after injectable PD-L1 inhibitor neglect

.Tracon Pharmaceuticals has chosen to relax procedures full weeks after an injectable immune system ...

Ideaya bags possibility on Biocytogen bispecific ADC in $400M bargain

.Ideaya Biosciences is betting $400 million in biobucks that a bispecific antibody-drug conjugate (A...

Takeda takes $140M reduction on neglected epilepsy drug, touts FDA manage

.Our company already recognize that Takeda is planning to find a road to the FDA for epilepsy medica...